The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Novartis AG (NVS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.07, or 0.08%, to $90.54. The Novartis AG has recorded 5,573 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Novartis presents pivotal Phase III APPLY-PNH data at ASH demonstrating investigational oral monotherapy iptacopan superiority over anti-C5.
The company is listed on the NYSE and operates within the Drug Manufacturers – General industry segment. At the end of the last regular session, the stock closed at $90.47 and fluctuated between $90.97 as its day high and $90.18 as its day low. The current market capitalization of Novartis AG is $215.25B. A total of 2.13 million shares were traded on the day, compared to an average of 2.03M shares.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Novartis AG pays an annual dividend of $3.33, resulting in a dividend yield of 3.68%, and it has a price to earnings (P/E) ratio of 9.32. NVS’s most recent ex-dividend date was 3/8/2022 when it declared a $1.1750 quarterly dividend that was paid in cash on 3/17/2022. Previously, the company paid the dividend on 3/15/2021 with an ex-dividend date of 3/4/2021. The NVS stock dividend was $3.3784 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for NVS in the last 3 months, the mean price target is $95.00 with high estimates of $111.57 and low estimates of $75.84. In terms of 52-week highs and lows, NVS has a high of $94.26 and a low of $74.09.
As of this writing, NVS has an earnings estimate of $1.55 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $1.61 per share and a lower estimate of $1.44. The company reported an EPS of $1.46 in the last quarter, which was 1.40% higher than expectations of $1.44.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 26 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVS is Sell with a score of 4.14. A total of 7 analysts rated the stock as Buy while 2 rated it as Overweight while 13 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 4 thought it should be Sold.